SMTL ID : 5mai.1

Crystal structure of MELK in complex with an inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 1 residues within 4Å: Chain A: F.207 1 PLIP interactions: 1 interactions with chain A pi-Cation interactions: A:F.207

1 x 5U5: 3-[(3~{Z})-3-[[[4-[(dimethylamino)methyl]phenyl]amino]-phenyl-methylidene]-2-oxidanylidene-1~{H}-indol-6-yl]-~{N}-ethyl-prop-2-ynamide(Non-covalent)

5U5.2: 16 residues within 4Å: Chain A: E.16, I.18, V.26, A.39, K.41, L.62, C.71, L.87, E.88, Y.89, C.90, E.94, L.140, I.150, D.151, F.152 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.26, A:L.62, A:L.140, A:I.150, A:I.150, A:I.150 Hydrogen bonds: A:K.41, A:C.71, A:E.88, A:C.90, A:D.151, A:F.152

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Klaeger, S. et al., The target landscape of clinical kinase drugs. Science (2017)

Release Date

2017-12-06

Peptides

Maternal embryonic leucine zipper kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Maternal embryonic leucine zipper kinase

Related Entries With Identical Sequence